Remedium Bio Secures $3.7 Million in Latest Pre-Series A Funding Round

Remedium Bio secured $3.7 million in its latest Pre-Series A, adding another data point to the Healthcare & Life Sciences funding market.

Remedium Bio Raises $3.7 million in Funding

Lifespan Vision Ventures Leads Remedium Bio's Series A Financing. Lifespan Vision Ventures is a global venture capital firm investing in early-stage biotechnology companies developing breakthrough technologies to prevent and treat age-related diseases.

Investors Behind the Funding

The round was backed by Valuence Ventures. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Remedium Bio operates in Healthcare & Life Sciences. Remedium Bio's financing adds to recent private-market activity.

Strategic Use of Funds

extend human healthspan

Looking Ahead

Lifespan Vision Ventures Leads Remedium Bio's Series A Financing

Source reference: original announcement/article.